Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Making a Hematopoietic Stem Cell.

Michael G Daniel1, Carlos-Filipe Pereira2, Ihor R Lemischka3

  • 1Department of Developmental and Regenerative Biology, Icahn School of Medicine, New York, NY, USA; Black Family Stem Cell Institute, Icahn School of Medicine, New York, NY, USA; The Graduate School of Biomedical Science, Icahn School of Medicine, New York, NY, USA.

Trends in Cell Biology
|November 4, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reprogramming Stars #28: Stem Cell-Based Approaches to Build Blood Vessels and Liver Tissue-An Interview with Dr. Lay Teng Ang.

Cellular reprogramming·2026
Same author

Protocol for identifying cellular reprogramming minimal networks using combinatorial transcription factor screening.

STAR protocols·2026
Same author

Reprogramming Stars #27: Drawing Inspiration from Reprogramming to Guide Stem Cell Differentiation: An Interview with Dr. Kyle Loh.

Cellular reprogramming·2026
Same author

A combinatorial transcription factor screening platform for immune cell reprogramming.

Cell systems·2026
Same author

Reprogramming Stars #26: Understanding the Reprogramming Privilege-An Interview with Dr. Shangqin Guo.

Cellular reprogramming·2025
Same author

Reprogramming Stars #25: Modeling Brain Aging with Direct Reprogramming of Skin Cells into Neurons-An Interview with Dr. Jerome Mertens.

Cellular reprogramming·2025
This summary is machine-generated.

Generating functional hematopoietic stem cells (HSCs) remains challenging. This review synthesizes recent strategies for HSC generation and expansion, highlighting the need for alternative approaches in stem cell therapy and drug discovery.

Area of Science:

  • Stem Cell Biology
  • Hematopoiesis
  • Regenerative Medicine

Background:

  • Generating hematopoietic stem cells (HSCs) in vitro has focused on ex vivo expansion or de novo generation from pluripotent stem cells (PSCs).
  • Induced pluripotent stem cells (iPSCs) address ethical concerns of embryonic stem cells (ESCs), but generating functional hematopoietic stem and progenitor cells (HSPCs) from them has proven difficult.
  • Direct reprogramming of somatic cells into HSCs and HSPCs is a new area of focus.

Purpose of the Study:

  • To review and synthesize recent strategies for generating and expanding hematopoietic stem cells (HSCs) in vitro.
  • To identify key findings and challenges in the field of HSC generation.
  • To underscore the necessity for alternative approaches to meet clinical demands for stem cell therapy and drug discovery.
Keywords:
hematopoiesishematopoietic stem cellreprogrammingtranscription factors

Related Experiment Videos

Main Methods:

  • Literature review of recent scientific publications on HSC generation and expansion.
  • Synthesis of strategies involving ex vivo expansion, de novo generation from PSCs, and direct reprogramming.
  • Analysis of key findings and limitations reported in the reviewed studies.

Main Results:

  • Previous methods using HSC expansion and PSC-derived HSPCs have yielded limited success.
  • Direct reprogramming of somatic cells shows promise but faces significant challenges in generating functional HSCs.
  • A critical need exists for novel and effective strategies to produce clinical-grade HSCs.

Conclusions:

  • Generating functional HSCs in vitro remains a significant hurdle for stem cell therapy and drug discovery.
  • Continued research into direct reprogramming and alternative methods is crucial.
  • Advancing HSC generation techniques is essential for future clinical applications and therapeutic development.